What is Palvella Therapeutics's other income (expense)?

Palvella Therapeutics (PVLA) reported other income (expense) of -$32K in Q1 2026.

How has Palvella Therapeutics's other income (expense) changed year-over-year?

Palvella Therapeutics's other income (expense) decreased by 114.3% year-over-year, from $224K to -$32K.

What does other income (expense) mean?

Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Palvella Therapeutics PVLA Other Income (Expense)

Other Income (Expense) at other companies

Relay Therapeutics, Inc.RLAY

$5.3M-32.1%

Viridian Therapeutics, Inc.VRDN

$11.27M+62.0%

ANI PharmaceuticalsANIP

-$651K-429%

PrecigenPGEN

-$1.94M+93.9%

Arcutis Biotherapeutics, Inc.ARQT

-$20K-110%

Kodiak Sciences IncKOD

-$22K-320%

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

Net margin71.7%+40.4pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Reported directly by Palvella Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's other income (expense)?: Palvella Therapeutics (PVLA) reported other income (expense) of -$32K in Q1 2026.
How has Palvella Therapeutics's other income (expense) changed year-over-year?: Palvella Therapeutics's other income (expense) decreased by 114.3% year-over-year, from $224K to -$32K.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.